These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8993549)

  • 41. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology.
    Lemberger T; Desvergne B; Wahli W
    Annu Rev Cell Dev Biol; 1996; 12():335-63. PubMed ID: 8970730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].
    Dubois M; Vantyghem MC; Schoonjans K; Pattou F
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):511-23. PubMed ID: 12527853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferator-activated receptor alpha.
    Sakai M; Matsushima-Hibiya Y; Nishizawa M; Nishi S
    Cancer Res; 1995 Nov; 55(22):5370-6. PubMed ID: 7585603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
    Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
    Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
    J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro.
    Duvanel CB; Honegger P; Pershadsingh H; Feinstein D; Matthieu JM
    J Neurosci Res; 2003 Jan; 71(2):246-55. PubMed ID: 12503087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.
    Tontonoz P; Singer S; Forman BM; Sarraf P; Fletcher JA; Fletcher CD; Brun RP; Mueller E; Altiok S; Oppenheim H; Evans RM; Spiegelman BM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):237-41. PubMed ID: 8990192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS; Coon CI; Rosen ED; Suh N; Sporn MB; Brinckerhoff CE
    Mol Pharmacol; 2004 Feb; 65(2):309-18. PubMed ID: 14742672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.
    Chu R; Madison LD; Lin Y; Kopp P; Rao MS; Jameson JL; Reddy JK
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11593-7. PubMed ID: 8524810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
    Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
    Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.
    Lecka-Czernik B; Moerman EJ; Grant DF; Lehmann JM; Manolagas SC; Jilka RL
    Endocrinology; 2002 Jun; 143(6):2376-84. PubMed ID: 12021203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
    Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
    Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment.
    Roberts-Thomson SJ
    Immunol Cell Biol; 2000 Aug; 78(4):436-41. PubMed ID: 10947870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone.
    Lappas M; Permezel M; Georgiou HM; Rice GE
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4667-72. PubMed ID: 12364456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
    Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
    Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.